Ultra-low-dose transdermal estrogen therapy in postmenopausal urogenital estrogen deficiency-a placebo-controlled study

Menopause

Volumn 1, Issue 4, 1994, Pages 191-198

  Nilsson, Kerstin E ^a   Heimer, Gun M ^b  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Transdermal therapy; Ultra low dose estradiol; Urogenital atrophy

Indexed keywords

EID: 0000115234     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/00042192-199424010-00003     Document Type: Article

References (22)

1. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-60.
2. Berg G, Gottvall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60-62 in Linkoping, Sweden, in 1986. Maturitas 1988;10:193-9.
3. Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990;12:51-60.
4. Lindgren R, Berg G, Hammar M, Zuccon E. Hormonal replacement therapy and sexuality in a population of Swedish postmenopausal women. Acta Obstet Gynecol Scand 1993;72:292-7.
5. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Emster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
6. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293-7.
7. Barrett-Connor E. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases. Am J Med 1993;95(suppl 5A):40-3.
8. v Schoultz B. Estrogens and urogenital epithelial function. Acta Obstet Gynecol Scand 1989(suppl 140):28-32.
9. Heimer G, Englund D. Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal. Acta Obstet Gynecol Scand 1984;63:563-7.
10. Nilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency-a pharmacokinetic and pharmacodynamic study. Maturitas 1992;15:121-7.
11. Smith P, Heimer G, Lindskog M, Ulmsten U. Oestradiol-releasing vaginal ring for the treatment of postmenopausal urogenital atrophy. Maturitas 1993;16:145-54.
12. Balfour JA, Heel RC. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Drugs 1990;40:561-82.
13. Illig R, DeCampo C, Lang-Muritano MR, Prader A, Torresani T, Werder EA, Willi U, Schenkel L. A physiological mode of puberty induction in hypogonadal girls by low dose transdermal 17β-oestradiol. Eur J Pediatr 1990;150:86-91.
14. Nilsson K, Heimer G. Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy. Gynecol Obstet Invest 1992;34:234-6.
15. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL. Biologic effects of transdermal estradiol. N Engl J Med 1986;314:1615-20.
16. Cardozo L. Role of estrogens in the treatment of female urinary incontinence. J Am Geriatr Soc 1990;38:326-8.
17. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6.
18. Bhatia N, Bergman A, Karram MM. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989;160:176-81.
19. Holmgren P-Å, Lindskog M, v Schoultz B. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy. Maturitas 1989;11:55-63.
20. Heimer GM, Englund DE. Effects of vaginally-administered oestriol on postmenopausal urogenital disorders: a cytohormonal study. Maturitas 1992;14:171-9.
21. Hahn RG. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol 1989;161:1854-8.
22. Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987;156:1332-4.